The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Treatment of fibromyalgia with cyclobenzaprine: A meta‐analysis
Abstract
Objective: To systematically review the effectiveness of cyclobenzaprine in the treatment of fibromyalgia. Methods: Articles describing randomized, placebo‐controlled trials of cyclobenzaprine in people with fibromyalgia were obtained from Medline, EMBase, Psyclit, the Cochrane Library, and Federal Research in Progress Database. Unpublished literature and bibliographies were also reviewed. Outcomes, including global improvement, treatment effects on pain, fatigue, sleep, and tender points over time, were abstracted. Results: Five randomized, placebo‐controlled trials were identified. The odds ratio for global improvement with therapy was 3.0 (95% confidence interval [95% CI] 1.6–5.6) with a pooled risk difference of 0.21 (95% CI 0.09–0.34), which calculates to 4.8 (95% CI 3.0–11) individuals needing treatment for 1 patient to experience symptom improvement. Pain improved early on, but there was no improvement in fatigue or tender points at any time. Conclusion: Cyclobenzaprine‐treated patients were 3 times as likely to report overall improvement and to report moderate reductions in individual symptoms, particularly sleep.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Goldenberg, D. L., Felson, D. T., & Dinerman, H. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291110 · Cited by 439
Goldenberg, D., Mayskiy, M., Mossey, C., Ruthazer, R., & Schmid, C. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391111 · Cited by 420
Treatment of fibromyalgia with antidepressants: A meta-analysis
O’Malley, P. G., Balden, E., Tomkins, G., Santoro, J., Kroenke, K., & Jackson, J. L. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.06279.x · Cited by 340
Self-citationComparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of Fibromyalgia
Carette, S., Bell, M. J., Reynolds, W. J., Haraoui, B., Mccain, G. A., Bykerk, V. P., Edworthy, S. M., Baron, M., Koehler, B. E., Fam, A. G., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370106 · Cited by 340
Evaluation of amitriptyline in primary fibrositis. A double‐blind, placebo‐controlled study
Carette, S., McCain, G. A., Bell, D. A., & Fam, A. G. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290510 · Cited by 303
Health status and disease severity in fibromyalgia. Results of a six‐center longitudinal study
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400905 · Cited by 273
A Double-blind Placebo Controlled Trial of Fluoxetine in Fibromyalgia
Wolfe, F., Cathey, M. A., & Hawley, D. J. (1994) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749409103725 · Cited by 252
A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis.
Clark, S., Tindall, E. A., & Bennett, R. M. (1985) · PubMed · Cited by 202
Russell, I. J., Fletcher, E. M., Michalek, J. E., McBroom, P. C., & Hester, G. G. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340507 · Cited by 200
A randomized controlled trial of citalopram in the treatment of fibromyalgia
Nørregaard, J., Volkmann, H., & Danneskiold-Samstøe, B. (1995) · Pain · doi:10.1016/0304-3959(94)00218-4 · Cited by 194
A comparison of cyclobenzaprine and placebo in the management of fibrositis
Bennett, R. M., Gatter, R. A., Campbell, S. M., Andrews, R. P., Clark, S. R., & Scarola, J. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311210 · Cited by 191
An Open Clinical Trial of Venlafaxine Treatment of Fibromyalgia
Dwight, M. M., Arnold, L. M., O’brien, H., Metzger, R., Morris-Park, E., & Keck, P. E. (1998) · Psychosomatics · doi:10.1016/s0033-3182(98)71375-1 · Cited by 159
Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo.
Biasi, G., Manca, S., Manganelli, S., & Marcolongo, R. (1998) · PubMed · Cited by 144
A prospective long‐term study of fibromyalgia syndrome
Kennedy, M., & Felson, D. T. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390422 · Cited by 126
Caruso, I., Puttini, P. S., Cazzola, M., & Azzolini, V. (1990) · Journal of International Medical Research · doi:10.1177/030006059001800304 · Cited by 120
Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989) · PubMed · Cited by 119
Cohn, L. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00021 · Cited by 119
Leventhal, L. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-11-199912070-00009 · Cited by 117
Scudds, R. A., McCain, G. A., Rollman, G. B., & Harth, M. (1989) · PubMed · Cited by 108
The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
Reynolds, W. J., Moldofsky, H., Saskin, P., & Lue, F. A. (1991) · PubMed · Cited by 96
Evaluation of s-adenosylmethionine in primary fibromyalgia
Tavoni, A. G., Vitali, C., Bombardieri, S., & Pasero, G. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90862-x · Cited by 94
Psychotropic treatment of chronic fatigue syndrome and related disorders.
Goodnick, P. J., & Sandoval, R. (1993) · PubMed · Cited by 90
A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
Quimby, L. G., Gratwick, G. M., Whitney, C. D., & Block, S. R. (1989) · PubMed · Cited by 80
Marder, W. D., Meenan, R. F., Felson, D. T., Reichlin, M., Birnbaum, N. S., Croft, J. D., Dore, R. K., Kaplan, H., Kaufman, R. L., & Stobo, J. D. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341002 · Cited by 79
A Double-Blind Crossover Study of Two Cyclobenzaprine Regimens in Primary Fibromyalgia Syndrome
Santandrea, S., Montrone, F., Sarzi‐Puttini, P., Boccassini, L., & Caruso, I. (1993) · Journal of International Medical Research · doi:10.1177/030006059302100202 · Cited by 54
Hamaty, D., Valentine, J. L., Howard, R., Howard, C., Wakefield, V., & Patten, M. S. (1989) · PubMed · Cited by 42
Oen, K., & Krzekotowska, D. (1989) · PubMed · Cited by 15
Cited by
EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850
“firmed the efficacy of cyclobenzaprine in FMS.(41) Two meta-analyses found that tricy-”
BackgroundFibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
Management of functional somatic syndromes
Henningsen, P., Zipfel, S., & Herzog, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60159-7 · Cited by 741
Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment
Bellato, E., Marini, E., Castoldi, F., Barbasetti, N., Mattei, L., Bonasia, D. E., & Blonna, D. (2012) · Pain Research and Treatment · doi:10.1155/2012/426130 · Cited by 389
Metadata
- Authors
- Tofferi, J. K., Jackson, J. L., & O'Malley, P. G.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2004-02-05
- Volume
- 51
- Issue
- 1
- Pages
- 9-13
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1491750971
- Cited by
- 273
- References
- 36
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.